Abstract: Estimating the direct effect of a treatment on an outcome is often the focus of epidemiological and clinical research, when the treatment has more than one specified pathway to the defined outcome. Even if the total effect is unconfounded, the direct effect is not identified when unmeasured variables affect the intermediate and outcome variables. Therefore, bounds on direct effects have been presented via linear programming under two common definitions of direct effects: controlled and natural. Here, we propose bounds on natural direct effects without using linear programming, because such bounds on controlled direct effects have already been proposed. To derive narrow bounds, we introduce two monotonicity assumptions that are weaker than those in previous studies and another monotonicity assumption. Furthermore, we do not assume that an outcome variable is binary, whereas previous studies have made that assumption. An additional advantage of our bounds is that the bounding formulas are extremely simple. The proposed bounds are illustrated using a randomized trial for coronary heart disease.
Introduction
The assessment of mediation is important for testing the mechanisms that explain an observed relationship between a treatment and an outcome. Investigators are often interested not only in the total effect of treatment on the outcome but also in the effect mediated through a particular pathway. For example, consider a hypothetical study evaluating the effect of smoking on cardiovascular disease (CVD), as in Robins and Greenland [1] . Smoking may cause CVD directly, but may also have an indirect effect through hyperlipemia. In such a study, one might be interested in the direct effect of smoking, that is, the effect that is not mediated through hyperlipemia. Unfortunately, the direct effect cannot be generally identified in the presence of unmeasured confounders between a mediator and an outcome, even if smoking is randomized. We will use this example throughout to illustrate our theories.
Two general categories of direct effects have been described in the literature: controlled direct effects (CDEs) and natural direct effects (NDEs) (e.g. [2] [3] [4] [5] [6] ). In the absence of a statistical interaction between the treatment and mediator, these two effects are identical; however, in the presence of an interaction, these effects differ. The CDEs quantify what would happen if the investigators conducted an experiment that fixed the mediator at a certain value; the CDEs are thus considered prescriptive [2] . In contrast, the NDEs are partitioned based on naturally occurring values of the intermediate variable; the NDEs are thus considered descriptive [2] .
Since CDEs and NDEs cannot generally be identified in the presence of unmeasured confounders between a mediator and an outcome, several researchers have discussed their bounds [7] [8] [9] [10] [11] , which is a strategy for inference on non-identified (causal) parameters. Recently, bounds on both direct effects were developed using a linear programming technique [7] [8] [9] . Although they have the advantage that they have the tightest width under the given assumptions, they also have the disadvantages that their use is limited to cases with a binary outcome and the given assumptions are very strict, that is, they must hold for all individuals. Therefore, bounds on CDEs that do not have these disadvantages have been developed without using linear programming [10, 11] , although the bounds may be less stringent than previous bounds that were derived via linear programming [7] . Here, we propose bounds on NDEs that do not have the disadvantages of previous bounds and that can be calculated using simple bounding formulas. Linear programming techniques are not used for the derivation. We further make three monotonicity assumptions at the population level rather than at the unit level and derive the bounds with narrower width under the assumptions.
The remainder of this manuscript is organized as follows. In Section 2, NDEs are defined in the framework of potential outcomes. We review the assumptions and bounds presented in previous literature using linear programming in Section 3 and propose new assumptions and bounds in Section 4. These bounds are illustrated using a randomized trial for coronary heart disease (CHD) in Section 5. Section 6 presents a discussion.
Natural direct effects
To model the presence of unmeasured confounders, we consider the directed acyclic graph (DAG) [12, 13] shown in Figure 1 , where X denotes a treatment, Z denotes a mediator, Y denotes an outcome, and U denotes an unmeasured confounder or a set of unmeasured confounders between Z and Y. It is assumed that the treatment X and mediator Z are binary variables, where X and Z are coded as taking the value of 0 or 1, and there is no confounding of X and (Z, Y). In this setting, the total effect of X on Y is identified, because there is no confounder between X and Y or between X and Z.
For each individual, we can also consider potential outcomes [2] corresponding to the outcome if an individual had been in a trial arm other than the one he/she was actually assigned. Let Z x be an individual's potential intermediate response when X is set to x, and Y x,z be the potential outcome when Z is set to z and X to x. Then, Y x;Z x Ã represents the potential outcome when setting X ¼ x and Z ¼ Z x Ã , where x Ã ¼ 0, 1. Using this expression, in the difference scale, the average NDEs are formulated as:
Unmeasured confounders (U ) Figure 1 A DAG for mediation process with a measured treatment X, a mediator Z, an outcome Y, and a set of unmeasured confounders U.
where the average CDEs are formalized as:
Here, we assume the no-interference [14] , which states that the outcome of an individual does not depend on the treatment and the mediator statuses of other individuals, and the mediator of an individual does not depend on the treatment status of other individuals. With this assumption, we do not need to set the treatment and mediator statuses of other individuals for an individual's potential outcome and, similarly, we do not need to set the treatment status of other individuals for an individual's potential intermediate response.
We also assume the consistency [15] , which means that the value of Z that would have been observed if X had been set to what in fact it was is equal to the value of Z that was observed, i.e. Z ¼ Z X . Similarly, the value of Y that would have been observed if X and Z had been set to what in fact they were is equal to the value of Y that was observed, i.e. Y ¼Y X,Z . Both no-interference and consistency are entailed by the stable unit treatment value assumption [16] . We further assume the following ignorability:
This assumption means that the treatment gives no information about the distributions of potential outcomes and potential mediators. This is implied by the DAG in Figure 1 . Because Y x,z represents the potential outcome when setting X ¼ x and Z ¼ z, when Y is replaced by Y x,z in Figure 1 , the direct arrows from X and Z to Y x,z are removed. In addition, an arrow from U to Z is removed for setting Z ¼ z. As a consequence, there is no path between X and Y x,z . Likewise, when Z is replaced by Z x in Figure 1 , a direct arrow from X to Z x is removed. Although there are paths between X and Z x through Y, Z x does not depend on X because Y is a common descendant of X and Z x . Under Assumption 1, E½Y x;Z x Ã can be expressed as:
½2
where the second equality is by the consistency assumption.
Previous assumptions and bounds
In this section, we review the assumptions and bounds presented via linear programming [8] and propose new assumptions and bounds in the next section. It is assumed that an outcome variable is binary and the following ignorability holds.
Assumption 1 Ã , which requires "joint" independence, is similar to, but a somewhat stronger assumption than Assumption 1, which requires "marginal" independence. For example, although Pr
Þholds even under Assumption 1. As noted in Section 1, here we discuss the bounds on the NDEs under assumptions at the population rather than the unit level. Therefore, we employ Assumption 1, which implies "mean" (rather than "full") independence, but not Assumption 1 Ã , which assumes "full" independence.
Under Assumption 1 Ã , the tight bounds on NDEs are
NDEð0Þ min
; ½4
where
These inequalities define the range within which the NDEs must lie and have the tightest width under Assumption 1 Ã .
To derive narrower bounds, the following monotonicity assumption has been presented [7, 8] .
Assumption 2 is the monotonicity assumption about a treatment and mediator and implies that the unit level causal effects of (i) X on Z, (ii) X on Y under the intervention on Z, and (iii) Z on Y under the intervention on X are in a particular direction. The bounds under Assumptions 1 Ã and 2 are
The use of the bounds given here is limited to cases with a binary outcome. Furthermore, Assumption 2 may be often unreasonable in practice, because it assumes monotonicity on three unit level causal effects, that is, for all individuals. Therefore, we seek alternative monotonicity assumptions and bounds.
Proposed monotonicity assumptions and bounds
In this section, we derive bounds on NDEs without assuming that an outcome variable is binary. RESULT 1. When the range of an outcome variable is defined, bounds on NDEs are as follows under Assumption 1:
is the range of y. These bounds are sharp.
PROOF. We have K 0 E½Y 1;Z0 K 1, because the range of y is (K 0 , K 1 ), and
. Therefore, these differences lead to bounds on NDE(0). Bounds on NDE(1) are also derived similarly. The proof of the sharpness is provided in Appendix 1. □
In the case of a binary outcome, Result 1 simplifies to
These bounds are equal to the candidates in previous bounds (eqs [3] and [4] ). Therefore, in the case of a binary outcome, Result 1 gives the same or broader bounds compared with previous bounds.
To derive narrower bounds on NDEs, we make three monotonicity assumptions at the population level rather than at the unit level, where two of them are weaker than the conditions in Assumption 2, in Sections 4.1-4.3.
Monotonicity of treatment
To derive narrower bounds, we make the following monotonicity assumption on treatment X.
This assumption means that the outcomes if subjects had taken X ¼ 1 are larger overall than those if they had taken X ¼ 0, for subpopulations with X ¼ x and Z ¼ z. For example, consider a hypothetical study evaluating the effect of smoking (X ¼ 1 if smoking and X ¼ 0 if non-smoking) on CVD (Y ¼ 1 if occurred and Y ¼ 0 if not occurred). CVD may tend to occur more frequently, if subjects were smokers compared to if they were non-smokers for subpopulations with X ¼ x and Z ¼ z, because smoking is a strong risk factor of CVD. Then, Assumption 3 holds. Assumption 3 is similar to, but weaker than, (ii) Y 0,z Y 1,z in Assumption 2, because it deals with expectation rather than unit level. Nevertheless, the following result shows that the lower bounds on NDEs under Assumptions 1 and 3 are equal to the candidates in the lower bounds of eq. [5] , that is, the lower bounds under Assumptions 1 and 2.
RESULT 2. Under Assumptions 1 and 3, bounds on NDEs are
These bounds are sharp.
PROOF. Substituting Assumption 3 with x = 0 into eq. [1] with (x, x Ã ) = (1, 0) yields:
where the second equality is by the consistency assumption, and
. The difference between them leads to the lower bound on NDE(0) of 0. Likewise, substituting Assumption 3 with
. Therefore, the lower bound on NDE (1) 
Monotonicity of the mediator
Assumption 3 may hold under some scenarios. In some situations, however, some investigators may suspect that this assumption does not hold, because they may think that the direct effect may be harmful even if it is considered that the overall effect is beneficial. Additionally, the upper bound cannot be improved under Assumption 3. Therefore, we introduce an alternative assumption to derive both bounds on NDEs.
This assumption means that the outcomes if subjects had taken Z = 1 are larger overall than those if they had taken Z = 0 for subpopulations with X ¼ x Ã and Z ¼ z and is similar to but weaker than (iii) Y x,0 ≤ Y x,1 in Assumption 2, because it deals with expectation rather than unit level. Again, consider a study evaluating the effect of smoking on CVD. CVD may tend to occur more frequently if the subjects had hyperlipemia than if they did not for subpopulations with X ¼ x Ã and Z ¼ z, because hyperlipemia is a strong risk factor for CVD. Then, Assumption 4 holds.
RESULT 3. Under Assumptions 1 and 4, bounds on NDEs are
PROOF. Substituting Assumption 4 with x ¼ 1 into eq.
[1] with ðx; x Ã Þ ¼ ð1; 0Þ yields:
½6 By applying Assumption 1 into this inequality, we have E½Y 1;Z0 ! E Y 1;0 Â Ã . A similar calculation yields
Bounds on NDEs are derived by applying
and by substituting eqs [7] and [8] into
The proof of the sharpness is provided in Appendix 1. □ Interestingly, under Assumptions 1 and 4, the lower bounds on NDE(x) are the same as those on CDE(z) with z ¼ x and the upper bounds on NDE(x) are the same as those on CDE(z) with z ≠ x. This is because 
Another monotonicity of the mediator
Bounds may still be wide under Assumptions 1 and 4, because the bounds (Result 3) include (K 0 , K 1 ), which is the range of y. However, when researchers consider that the following monotonicity assumption about the mediator is reasonable in the situation that they encounter, we can derive the bounds on NDEs with narrower width.
This assumption means that the potential outcomes for subjects who actually took Z ¼ 1 are overall larger than those for subjects who actually took Z ¼ 0, within the stratum of x. This assumption is a mediation analysis version of an assumption that is sometimes referred to as monotone treatment selection [17, 18] . In a study evaluating the effect of smoking on CVD, the subpopulation that has hyperlipemia (Z ¼ 1) will likely be unhealthier overall than the subpopulation that does not have hyperlipemia (Z ¼ 0) under the same smoking status. That is because, for x ¼ 0, the first subpopulation has hyperlipemia despite being non-smokers, while the second subpopulation may not have hyperlipemia because they are non-smokers. Therefore, the subpopulation with X ¼ 0 and Z ¼ 1 will likely overall tend to have CVD more frequently than the subpopulation with X ¼ 0 and
These observations show that Assumption 5 holds. When Assumptions 1, 4, and 5 hold, we have the following result. 
PROOF. Under Assumptions 1 and 4, eq. [6] holds. By applying Assumption 1 to eq. [6], we have
and further by substituting Assumption 5 with (x, z) ¼ (1, 0) into this inequality and applying the consistency assumption, we obtain
A similar calculation yields
The differences between these inequalities and E½Y 0;Z0 ¼ E Y j X ¼ 0 ½ lead to bounds on NDE(0). Likewise, by applying Assumptions 1, 4, and 5, we obtain E Y j X ¼ 0;
The difference between this inequality and E½Y 1; We note that E Y x;0
, which were derived in the proof of Result 4, can be obtained by applying the following assumption instead of Assumption 5 [10, 11] .
ASSUMPTION 5
Ã . There exists univariate U such that Y x;z ' Zj X; U f g and both
Þ are either non-decreasing or both non-increasing in u for all x.
Assumption 5 Ã implies Assumption 5, as seen in Appendix 2. We further note that, under Assumptions 1, 4, and 5 (or 5 Ã ), the lower bounds on NDE(x) are the same as those on CDE(z) with z ¼ x and the upper bounds on NDE(x) are the same as those on CDE(z) with z ≠ x, similar to Result 3.
Illustration
We illustrate the proposed bounds using data from the Lipid Research Clinics Coronary Primary Prevention Trial (LRC-CPPT) [19, 20] . These are the same data as used to illustrate previous bounds that were developed via linear programming [8] .
The LRC-CPPT was a randomized trial designed to evaluate the efficacy of the cholesterol-lowering drug cholestyramine for the prevention of CHD in 3,806 asymptotic middle-aged men with hypercholesterolemia. In this study, 1,888 subjects were randomized to a cholestyramine treatment (X ¼ 0) and 1,918 subjects to a placebo (X ¼ 1). During a follow-up period of 1 year, each CHD event was recorded (Y ¼ 0 for no event and Y ¼ 1 for an event). At the end of follow-up, cholesterol levels were recorded for each subject. Previous studies [7, 8, 20 ] dichotomized cholesterol levels as Z ¼ 0 for < 280 mg/dL and Z ¼ 1 for ! 280 mg/dL. The data from the LRC-CPPT are shown in Table 1 . Note that this example is for illustrative purposes only, as the mediator Z has been dichotomized, and this can give rise to misleading influences.
Bounds on NDEs under the assumptions given above are shown in Table 2 , where the bounds under Assumption 1 Ã were yielded by using eqs [3] and [4] . We note that Result 1 yielded bounds on NDE (0) and NDE(1) of (-6.89 × 10 -2 , 93.11 Â 10 -2 ) and (-91.24 Â 10 -2 , 8.76 Â 10 -2 ), respectively, where the lower bound on NDE(0) and the upper bound on NDE (1) were the same as the previous ones. Under Assumption 1 
Discussion
We have proposed three monotonicity assumptions and bounds on NDEs along with these assumptions when treatment is randomized. As compared with previous assumptions and bounds, our assumptions and bounds have the following advantages: (i) their use is not limited to a binary outcome; (ii) the bounding formulas are very simple and thus the variances for estimates of the bounds are easily calculated: we can simply use sample variances for two of our assumptions are weaker than previous ones, because we make the assumptions on expectation rather than unit level. Furthermore, our assumptions and bounds are extended straightforwardly to relax Assumption 1 from unconditional ignorability to conditional ignorability given some observed pretreatment covariates. This extension is achieved by considering bounds on E½Y 1;Z x jC À E½Y 0;Z x jC rather than E½Y 1;Z x À E½Y 0;Z x , where C is a pretreatment covariate or a set of pretreatment covariates; Then, bounds on the NDEs are evaluated by
, and 4 and use the delta method for the variance of product of
When the monotonicity assumptions, such as Assumptions 3-5, are assumed for each stratum with C ¼ c, bounds on causal effects derived under conditional ignorability may further narrow down those under unconditional ignorability, although the variances for estimates of the bounds are inflated.
We need to note that our assumptions still have the limitation that we cannot empirically confirm whether our assumptions hold. We can say that at least one of the given assumptions does not hold if the upper bound on NDE(x) minus the lower bound on NDE(x) takes a negative value. Unfortunately, for Results 1-3, such calculations definitely yield positive values. However, for Result 4, if at least one of
, 1 takes a negative value, we can say that at least one of the given assumptions does not hold. Note that we cannot still say that the given assumptions hold even if the observed data yields
Nevertheless, our assumptions may be reasonable in some situations, as discussed using a hypothetical study evaluating the effect of smoking on CVD.
The proposed bounds shown in Table 2 are remarkably narrow, given the relatively weak assumptions invoked, although the upper bounds under previous assumptions are smaller than those under ours. This shows that the proposed bounds have greater potential use as compared with those in much of the previous literature.
Appendix 1: Proof that the bounds in Results 1-4 are sharp
Here, we prove only the sharpness of the bounds on NDE(0). To prove this, it is enough to show the sharpness of the bounds for E½Y 1;Z0 , because E½Y 0;Z0 can be estimated by E Y j X ¼ 0 ½ from the observed data. The sharpness of the bounds on NDE(1) is proved in a similar manner.
Proof that the bounds in Result 1 are sharp
It is enough to show that K 0 E½Y 1;Z 0 K 1 is sharp under Assumption 1.
For the following distribution that is consistent with the observed data and Assumption 1:
we consider the following degenerate distribution:
By the consistency assumption, E½Y 1;Z 0 evaluated under the distribution equals:
must be contained in any bounds on E½Y 1;Z 0 , because eq. [11] holds for any point in the interval. This shows that the bounds in Result 1 are sharp. Note that this logic of the proof follows that by Heckman and Vytlacil [21] , which was used to prove the sharpness of bounds on the average causal effect when the instrumental variable is observed. This logic is also applied to the following proofs that the bounds in Results 2-4 are sharp, in which it is further proven that the distribution with degenerate distributions such as eq. [10] is consistent with additional assumptions.
Proof that the bounds in Result 2 are sharp
It is enough to show that E Y j X ¼ 0 ½ E½Y 1;Z0 K 1 is sharp under Assumptions 1 and 3. For the joint distribution [9] , we consider the following degenerate distribution instead of eq. [10] : 
, is satisfied by eq. [12] with z = 0 and Assumption 3 with x; z ð Þ ¼ 0;
is satisfied by eq. [12] with z = 1. Thus, the joint distribution [9] with eq. [12] is consistent with Assumption 3. Furthermore, E½Y 1;Z 0 evaluated under the distribution equals eq. (11) with the replacement of k 1 (z) with k 2 (z), where
Thus, every point in E ½ ½Y 0;z j Z 0 ¼ z ; K 1 must be contained in any bounds on E½Y 1;Z0 , because eq. [11] holds for any point in the interval. This shows that the bounds in Result 2 are sharp.
Proof that the bounds in Result 3 are sharp
It is enough to show that: which is identical to eq. [9] with the replacement of z 0 with z 1 . Here, we consider the following degenerate distributions:
where k
Likewise, E Y 1;1 Â Ã evaluated under the distribution equals:
can be evaluated as follows:
under the joint distribution [13] with the degenerate distribution:
, which is the interval including both intervals of k 
is satisfied by eq. [15] with (z, z 1 ) ¼ (1, 0) . Thus, the joint distribution [13] with eq. [15] is consistent with Assumption 4. Furthermore, eq. [14] yields
Thus, every point in the intervals of k 3 (z,z 1 ) must be contained in any bounds on E½Y 1;Z 0 . This shows that the bounds in Result 3 are sharp.
Proof that the bounds in Result 4 are sharp
It is enough to show that E Y j X ¼ 1; 
where k 
where To show that Assumption 5 Ã implies Assumption 5, we apply the following lemma [22] . LEMMA 1. Let f and g be functions with n real-valued arguments such that both f and g are non-decreasing in each of their arguments. If U ¼ U 1 ; . . . ; U n ð Þis a multivariate random variable with n components such that each component is independent of the other components, then Covff U ð Þ; g U ð Þg ! 0.
The proof is as follows:
The second equality is by Y x;z ' ZjfX; Ug. The first inequality follows, because by Lemma 1, where both f x; U ð Þ¼ E Y j X ¼ x; Z ¼ z; U ¼ u ½ and g x; U ð Þ ¼ Pr Z ¼ 1 j X ¼ x; U ¼ u ð Þ are non-decreasing in u. Likewise, the second inequality follows because E Y j X ¼ x; Z ¼ z; U ¼ u ½ is non-decreasing in u and Pr Z ¼ 0 j X ¼ x; U ¼ u ð Þ is non-increasing in u. A similar calculation holds in the case in which both f x; U ð Þ and g x; U ð Þ are non-increasing in u. We thus see that Assumption 5 Ã implies Assumption 5.
